West Pharmaceutical Services Inc (WST)
333.23
+0.70
(+0.21%)
USD |
NYSE |
Jan 08, 12:00
West Pharmaceutical Services Research and Development Expense (Quarterly): 15.50M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merit Medical Systems Inc | 20.53M |
| Repligen Corp | 9.71M |
| Perspective Therapeutics Inc | 12.03M |
| Xtant Medical Holdings Inc | 0.701M |
| Catheter Precision Inc | 0.063M |